What is an iron infusion?
An iron infusion is the delivery of a licensed intravenous iron preparation directly into a vein through a cannula. The iron is bound inside a carbohydrate shell, taken up by cells of the reticuloendothelial system, and then released for use in making haemoglobin and for storage. It replaces iron stores in one or two visits rather than over months.
Unlike an iron tablet, which must survive the stomach and be absorbed across the gut wall, an intravenous preparation bypasses the digestive tract entirely. That is the main reason it is used: it works in people whose gut cannot absorb iron, and it can replace a large deficit in a short time. It is a treatment for a documented deficiency, not a general wellness infusion.
Intravenous iron is a prescription medicine. In the UAE it can only be given in a licensed healthcare facility by qualified staff, after a doctor has assessed the patient, because hypersensitivity reactions — though uncommon — require immediate recognition and treatment. The product summary of characteristics for ferric carboxymaltose states explicitly that the diagnosis of iron deficiency must be based on laboratory tests.
Diagnosis first, infusion second
Iron deficiency is a finding, not a diagnosis. In adults it can be the first sign of gastrointestinal blood loss, coeliac disease or gynaecological pathology. Correcting the iron without asking why it was low can mask a condition that needs investigating in its own right.
Sources: Ferinject (ferric carboxymaltose) — Summary of Product Characteristics, emc; Snook J et al. — British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults, Gut 2021
What is the difference between iron deficiency and iron-deficiency anaemia?
Iron deficiency means body iron stores are low. Iron-deficiency anaemia means the stores have fallen far enough that the bone marrow can no longer maintain a normal haemoglobin level. The first can exist for a long time with a completely normal full blood count, which is why a normal haemoglobin result does not by itself rule iron deficiency out.
The distinction matters clinically because it changes both the urgency and the threshold for treatment. Anaemia is the later stage; iron deficiency without anaemia is the earlier one. Symptoms attributed to the earlier stage — fatigue in particular — overlap with a very long list of other causes, and the evidence that treating non-anaemic iron deficiency reliably improves fatigue is mixed rather than settled. That uncertainty should be part of the conversation before any infusion, not after it.
Iron deficiency
Low stores, typically reflected in a low ferritin. Haemoglobin may still be normal. Treatment depends on the cause, the size of the deficit and the symptoms.
Iron-deficiency anaemia
Low haemoglobin plus evidence of iron deficiency, often with small, pale red cells (low MCV and MCH) on the full blood count.
Anaemia of inflammation
Chronic inflammation raises ferritin and lowers available iron at the same time, which can make ferritin look reassuring when stores are not. Interpretation needs a doctor, not a threshold.
Sources: WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations (2020); NHS — Iron deficiency anaemia
Which blood tests should be done before an iron infusion?
At minimum a full blood count and a serum ferritin, usually with transferrin saturation and often C-reactive protein to detect inflammation that may distort the ferritin result. These establish whether iron deficiency is actually present, how large the deficit is, and give a baseline against which the response to treatment can later be measured.
| Test | What it shows | Why it is needed before infusion |
|---|---|---|
| Full blood count | Haemoglobin, red cell size (MCV) and haemoglobin content (MCH) | Distinguishes deficiency with anaemia from deficiency without it, and flags other blood disorders |
| Serum ferritin | An indirect marker of stored iron | The single most useful test for iron stores, but it rises with inflammation, infection and liver disease |
| Transferrin saturation | How much iron is available for transport and use | Helps confirm deficiency when ferritin is difficult to interpret, and helps identify iron overload |
| CRP or other inflammatory marker | Presence of an inflammatory state | A raised CRP means the ferritin must be interpreted at a higher threshold |
British Society of Gastroenterology guidance also stresses the parallel question of cause. In adult men and in women after the menopause, unexplained iron-deficiency anaemia warrants investigation of the gastrointestinal tract, because occult blood loss is a recognised cause. Coeliac serology is recommended in confirmed iron-deficiency anaemia. An infusion given without that work-up treats the number and ignores the reason.
Screening infusions are not a recognised practice
There is no evidence base for giving intravenous iron to people who have not been shown to be iron deficient, and doing so risks iron overload. Anyone offered an iron infusion without prior blood tests should ask why.
Sources: Snook J et al. — BSG guidelines for the management of iron deficiency anaemia in adults, Gut 2021;70:2030–2051; NICE — Chronic kidney disease: assessment and management (NG203)
Who is intravenous iron usually recommended for?
Intravenous iron is generally reserved for people with confirmed iron deficiency who cannot take, cannot absorb, or have not responded to oral iron, and for those who need iron stores restored quickly. It is not a first-line treatment for straightforward iron deficiency that responds to tablets.
- Malabsorption — coeliac disease, previous bariatric or gastric surgery, or other conditions that impair absorption in the upper small bowel
- Inflammatory bowel disease, where oral iron may be poorly tolerated and may aggravate gastrointestinal symptoms
- Intolerance of oral iron — persistent nausea, constipation or abdominal pain that prevents an adequate course being completed
- Failure of oral iron — an inadequate haemoglobin or ferritin response despite adherence to a proper course
- Heavy menstrual bleeding, where ongoing losses outpace what oral supplementation can replace
- Chronic kidney disease, particularly in patients on dialysis, where intravenous iron is standard practice under specialist care
- The peri-operative setting, where correcting anaemia before major surgery is part of patient blood management
- Pregnancy, in the second and third trimesters, where specifically indicated and under obstetric supervision
Suitability, product choice and dose are all clinical decisions. The dose is calculated from body weight and the size of the iron deficit, not chosen from a menu, and some patients need a second infusion some weeks after the first.
Sources: Snook J et al. — BSG guidelines for the management of iron deficiency anaemia in adults, Gut 2021; NICE — Chronic kidney disease: assessment and management (NG203)
Who should not have an iron infusion?
Intravenous iron is contraindicated in anaemia not caused by iron deficiency, in iron overload or disorders of iron utilisation, and in anyone with a known serious hypersensitivity to the product or to other parenteral iron preparations. It is also generally deferred during active infection and, as a rule, in the first trimester of pregnancy.
- Anaemia that is not due to iron deficiency — giving iron does not correct it and adds risk
- Iron overload, including haemochromatosis, or disturbances in iron utilisation
- Previous serious hypersensitivity reaction to an intravenous iron product
- Active or acute infection — iron is deferred until the infection is treated
- First trimester of pregnancy — intravenous iron is generally avoided; use later in pregnancy is a specialist decision
- Significant liver disease or a history of allergy, asthma or eczema, which call for extra caution and assessment
Every patient is assessed individually
This list is general information, not a substitute for assessment. Only the prescribing doctor, with the blood results and full medical history in front of them, can decide whether an infusion is appropriate.
Sources: Ferinject (ferric carboxymaltose) — Summary of Product Characteristics, sections 4.3 and 4.4
Which intravenous iron products are used?
Several licensed preparations exist. The ones most often encountered in current practice are ferric carboxymaltose, iron sucrose and ferric derisomaltose. They differ in how much iron can be given in a single session, how long the infusion takes, and in their side-effect profiles.
| Preparation | Practical characteristics |
|---|---|
| Ferric carboxymaltose | Allows a large dose in a single relatively short session, so a full replacement course can often be completed in one or two visits. Carries a substantially higher rate of hypophosphataemia than ferric derisomaltose. |
| Iron sucrose | An older, well-established preparation. The maximum dose per session is smaller, so more visits are usually needed to deliver the same total amount of iron. |
| Ferric derisomaltose | Also permits high single doses. In two randomised trials it produced a lower incidence of hypophosphataemia than ferric carboxymaltose over 35 days. |
Older high-molecular-weight iron dextran products, which carried a higher risk of severe reactions, have largely been withdrawn from routine use. The preparations in current use have a substantially better safety record, but they are not risk-free and are still given in a setting equipped to manage a reaction.
Sources: Wolf M et al. — Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials, JAMA 2020; Rampton D et al. — Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management, Haematologica 2014
What happens during an iron infusion appointment?
After a check of identity, history and blood results, a cannula is placed in a vein and the diluted iron preparation is infused, typically over 15 to 30 minutes depending on the product and dose. Observation continues for at least 30 minutes after the infusion finishes, because most reactions occur during or shortly after administration.
- 1
Pre-infusion check
Confirmation of the diagnosis and blood results, review of allergy history, current infections and pregnancy status, and calculation of the dose from body weight and iron deficit.
- 2
Cannulation and monitoring setup
A cannula is placed, usually in the forearm or hand. Baseline observations are recorded and the cannula site is checked for correct placement.
- 3
The infusion
The preparation is given as a slow infusion. Staff monitor for early signs of a reaction, and the site is watched to make sure the fluid is not leaking into the surrounding tissue.
- 4
Observation period
Monitoring continues for at least 30 minutes after the infusion ends. Product guidance specifies that patients are observed for signs of hypersensitivity during and after each administration.
- 5
Aftercare and follow-up plan
The patient is given written information on delayed side effects, told what to report, and given a date for repeat blood tests.
Sources: Ferinject (ferric carboxymaltose) — Summary of Product Characteristics, section 4.4
What are the side effects and risks of an iron infusion?
Common effects include headache, nausea, a metallic taste, flushing and reactions at the injection site. Less common but important risks are hypersensitivity reactions, the self-limiting Fishbane reaction, transient low blood phosphate with certain preparations, and permanent brown skin staining if the infusion leaks out of the vein.
Common, usually short-lived
Headache, nausea, dizziness, flushing, a temporary metallic taste, and pain, bruising or irritation at the cannula site. These typically settle within a day or two.
Hypersensitivity reactions
Uncommon but serious reactions can occur, which is why infusions are given only where staff and equipment are available to treat them immediately. Any breathing difficulty, swelling or collapse is a medical emergency.
Fishbane reaction
An acute, self-limiting reaction with transient flushing and truncal myalgia — aches in the back and chest — sometimes with joint pains, reported in roughly 1 in 100 people given intravenous iron. Symptoms settle spontaneously over a few minutes and it is not anaphylaxis, but it has to be recognised as distinct from it.
Hypophosphataemia
A fall in blood phosphate can follow intravenous iron and is far more frequent with ferric carboxymaltose than with ferric derisomaltose — in two randomised trials it occurred in roughly three quarters of patients given ferric carboxymaltose versus around 8% given ferric derisomaltose. It is often without symptoms and resolves, but the ferric carboxymaltose product information records post-marketing reports of symptomatic hypophosphataemia leading to osteomalacia and fractures requiring clinical intervention, including surgery.
Skin staining from extravasation
If the preparation leaks into the tissue around the vein, it can leave a grey-blue or brown mark on the skin. Rates of roughly 0.68% to 1.3% have been reported in clinical trials. In many cases the staining is permanent, although some patients report that it fades over time.
Patients are rarely warned about skin staining — they should be
Extravasation staining is an uncommon complication, but it is visible, cosmetically significant and may not fade. It should be part of the consent conversation before the cannula goes in, alongside the instruction to report any pain, stinging or swelling at the site immediately during the infusion.
Sources: Rampton D et al. — Hypersensitivity reactions to intravenous iron, Haematologica 2014 (Fishbane reaction); Wolf M et al. — Hypophosphatemia after ferric derisomaltose vs ferric carboxymaltose, JAMA 2020; Canning M, Grannell L — A stain on iron therapy, Australian Prescriber 2020; Ferinject (ferric carboxymaltose) — Summary of Product Characteristics, section 4.4 (hypophosphataemia)
How is the response to an iron infusion monitored?
Blood tests are repeated after the infusion to confirm that haemoglobin and iron stores have responded. Ferritin is usually rechecked no earlier than about four to eight weeks afterwards, because intravenous iron temporarily raises ferritin and an early test can give a falsely reassuring result.
Haemoglobin generally begins to rise within two to four weeks of adequate iron replacement, but replenishing stores takes longer. A repeat full blood count and ferritin at the interval the treating doctor specifies confirms whether the deficit has actually been corrected, or whether ongoing losses mean the underlying cause is still active.
Where symptoms were the reason for treatment, those should be reviewed honestly at follow-up too. If iron stores are restored and the symptoms have not changed, the sensible conclusion is that iron was not their cause — and repeating the infusion is not the answer.
Sources: Snook J et al. — BSG guidelines for the management of iron deficiency anaemia in adults, Gut 2021
How does oral iron compare with an infusion?
Oral iron remains first-line for most people with iron deficiency: it is inexpensive, does not require a cannula, and carries none of the infusion-related risks. Its drawbacks are gastrointestinal side effects, slow correction of the deficit, and ineffectiveness where absorption is impaired.
| Oral iron | Intravenous iron | |
|---|---|---|
| Speed of replacement | Months of consistent dosing | Weeks; the full dose is delivered in one or two sessions |
| Main drawbacks | Nausea, constipation, dark stools, abdominal discomfort; adherence often poor | Requires a cannula and supervised setting; hypersensitivity, hypophosphataemia and extravasation risks |
| Works if the gut cannot absorb | No | Yes — the digestive tract is bypassed |
| Typical role | First-line for most patients | Second-line, or first-line in specific clinical situations |
Dosing schedule matters more than many people realise. Randomised work by Stoffel and colleagues found that oral iron raises the hormone hepcidin for around 24 hours, which suppresses absorption of subsequent doses — so alternate-day single doses were absorbed better than daily or twice-daily divided doses. People who concluded that oral iron did not work for them may not have had a fair trial of it.
Sources: Stoffel NU et al. — Iron absorption from oral iron supplements given on consecutive versus alternate days, The Lancet Haematology 2017; NHS — Iron deficiency anaemia: treatment
Where should someone in Dubai start?
The first step is a consultation with a licensed doctor and a blood test — not booking an infusion. Iron status has to be confirmed, the cause of any deficiency identified, and suitability assessed before intravenous iron is appropriate.
Intravenous iron must be prescribed and administered in a DHA-licensed facility with staff and equipment on hand to manage a reaction. Anywhere offering an iron infusion without prior blood tests, or as an off-the-shelf wellness package, is not following recognised practice.
Choose a DHA-licensed clinic that confirms iron deficiency with appropriate blood tests, investigates why it occurred, discusses oral treatment, and calculates any intravenous dose from clinical need rather than offering a fixed package.
Frequently asked questions
How long does an iron infusion take?
The infusion itself commonly takes 15 to 30 minutes, depending on the preparation and the dose. Patients are then observed for at least a further 30 minutes. Allowing around two hours for the whole appointment, including checks and cannulation, is realistic.
Can I have an iron infusion just because I feel tired?
No. Fatigue has many causes, and intravenous iron is only appropriate where blood tests confirm iron deficiency. Giving iron to someone who is not deficient offers no benefit and risks iron overload. The correct first step is a blood test to find out whether iron is actually the issue.
How soon will I feel a difference after an iron infusion?
Haemoglobin typically starts to rise within two to four weeks where iron deficiency was the cause of anaemia, and symptoms may improve over a similar period. Reports of feeling better within a day or two are not explained by the biology of red cell production. Where deficiency was not the cause of the symptoms, an infusion may not change them at all.
Does an iron infusion hurt?
Placing the cannula feels like a normal blood test. The infusion itself is usually painless. Any pain, stinging, burning or swelling at the cannula site during the infusion should be reported to staff straight away, because it may indicate the fluid is leaking into the tissue — which can cause lasting skin discolouration.
Can I have an iron infusion while pregnant?
Intravenous iron is generally avoided in the first trimester. In the second and third trimesters it may be used where specifically indicated, under obstetric supervision, with the benefits and risks assessed individually. This is a decision for the treating obstetrician, not a routine option.
How many iron infusions will I need?
That depends on the size of the iron deficit, body weight and which preparation is used. Some people need one session; others need a second some weeks later. The total dose is calculated by the prescribing doctor rather than chosen in advance.
Where can I be assessed for an iron infusion in Dubai?
Through a DHA-licensed clinic, starting with a consultation and blood tests. Verify the facility and clinician licences, and expect the cause of the deficiency and oral alternatives to be considered. Intravenous iron should be given only if the results and medical assessment support it.